Karaoglu, A. Et Al. 2003. Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors. TUMORI , vol.89, no.2 , 141-145.

Karaoglu, A., Yalcin, S., Tekuzman, G., Kars, A., Celik, I., Guler, N., ... Ozisik, Y.(2003). Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors. TUMORI , vol.89, no.2, 141-145.

Karaoglu, AZİZ Et Al. "Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors," TUMORI , vol.89, no.2, 141-145, 2003

Karaoglu, AZİZ Et Al. "Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors." TUMORI , vol.89, no.2, pp.141-145, 2003

Karaoglu, A. Et Al. (2003) . "Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors." TUMORI , vol.89, no.2, pp.141-145.

@article{article, author={AZİZ KARAOĞLU Et Al. }, title={Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors}, journal={TUMORI}, year=2003, pages={141-145} }